SNYWatch

Sanofi

$45.54

Community outlook

Mixed52%

Questions Discussion Earnings Data & analysis

Next report

Thu, 30 Jul 2026

tomorrowbefore market open

EPS estimate

$1.92

Wall Street consensus

Revenue estimate

$11.3B

Wall Street consensus

Expected swing

±1.9%

±1σ by report day, from realized volatility

Also reporting that week:BA KO PYPL V ARM HOOD META MSFT

EPS outlook

Odds turned into a number: where the print lands if SNY's usual surprise repeats — and what the crowd's beat odds imply on the same scale.

Street estimate

$•.••

the bar to clear

If history repeats

$•.••

•• of •• quarters beat

Crowd implies

—

needs more forecasts on the beat question

Typical range for the print: $•.•• – $•.••±1σ of past surprises
Beat odds implied by the record: ••%ceiling on •• quarters

A beat probability is a statement about where the print sits relative to the estimate. Scaled by how far recent quarters landed from the Street, it becomes a dollar figure. Not a forecast of the stock — companies fall on beats.

The crowd's read

Live odds from the community — tap through to make your own call.

Will Sanofi close higher a week from now?

Nearest crowd call that settles after the report · 6 forecasting

53%

Forecast

The Street's stance

Analyst consensus — and whether it has been improving or souring into the print.

Buy

29 analysts · 16 buy · 12 hold · 1 sell

steady over the last 3 months

Estimate track record

Reported EPS against the Street's estimate, most recent first — the same feed our earnings questions settle on.

Beat rate

3 of 4

quarters beat the estimate

Avg surprise

+3.1%

vs EPS estimate

Quarter	Estimate	Actual	Surprise	Result
Mar 2026	$1.81	$1.88	+4.1%	BEAT
Dec 2025	$1.46	$1.53	+4.6%	BEAT
Sept 2025	$2.75

Fundamentals snapshot

Trailing-twelve-month figures for context around the print.

Market cap

$94.0B

EPS (TTM)

$10.00

P/E (TTM)

7.7

price ÷ trailing earnings

Revenue growth

+43.7%

TTM vs a year ago

Gross margin

72.5%

of revenue kept after costs

Net margin

17.2%

of revenue kept as profit

52-week range

$71 – $91

now $45.54

Beta

0.92

moves with the market

Dividend yield

10.15%

Estimates and reported figures via Finnhub; crowd odds are Sanofi forecasts on Probs. Information, not investment advice.